Skip to main content
MYGN logo
MYGN
(NASDAQ)
Myriad Genetics, Inc.
$3.20-- (--)
Loading... - Market loading

Myriad Genetics (MYGN) Stock Price & Financial Analysis

Myriad Genetics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.12 - $3.26
52-Week High$8.59
52-Week Low$2.74
Open$3.22
Volume1.28M
Average Volume (3M)2.14M
Market Cap303.36M
Shares Outstanding94.80M
Price to Sales (P/S)0.36
Price to Book (P/B)0.95
EV/EBITDA-5.07
Revenue (TTM)806.60M
Net Income (TTM)-112.60M
Free Cash Flow (TTM)-20.80M
EPS (TTM)$-1.20
Profit Margin-13.96%
Operating Margin-11.55%
Return on Equity (ROE)-37.05%
Debt to Equity0.40
50-Day MA$4.83
200-Day MA$5.33
52-Week Change-46.58%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateJul 1, 2009

Frequently Asked Questions About Myriad Genetics

What is the current stock price for MYGN?

As of the latest trading session, MYGN stock trades at $3.20. The 52-week range is $2.74–$8.59, with a day range of $3.12–$3.25.

What is the P/E ratio for MYGN?

The P/E ratio (Price-to-Earnings) for MYGN is shown in the Key Statistics section. This valuation metric helps compare Myriad Genetics, Inc. to industry peers.

Does MYGN pay dividends?

Myriad Genetics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MYGN?

Based on 1 analyst, the consensus for MYGN is Sell.

What is the market cap of MYGN?

Myriad Genetics's market capitalization is $303.4M, classifying it as a small-cap company. Myriad Genetics operates in the Healthcare sector within the Diagnostics & Research industry.